Company Filing History:
Years Active: 1998
Title: Gregory Ricardo Martinez: Innovator in Benzocycloalkylazolethione Compounds
Introduction
Gregory Ricardo Martinez is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds that have potential therapeutic applications.
Latest Patents
Martinez holds a patent for "Benzocycloalkylazolethione derivatives and processes for preparing the." This invention relates to unique benzocycloalkylazolethione compounds that act as dopamine β-hydroxylase inhibitors. The compounds feature a benzocycloalkyl portion selected from various structures, including indanyl and tetrahydronaphthalenyl, and an azolethione portion that includes specific thioxo derivatives. The patent also covers prodrugs, pharmaceutically acceptable salts, individual isomers, and methods for using and preparing these compounds.
Career Highlights
Gregory Ricardo Martinez is associated with Syntex (U.S.A.) Inc., where he has been instrumental in advancing research and development in pharmaceutical chemistry. His work has contributed to the understanding and application of dopamine β-hydroxylase inhibitors, which may have implications in treating various medical conditions.
Collaborations
Throughout his career, Martinez has collaborated with esteemed colleagues, including Owen W. Gooding and David Bruce Repke. These collaborations have fostered innovation and enhanced the research output in their respective fields.
Conclusion
Gregory Ricardo Martinez is a distinguished inventor whose work on benzocycloalkylazolethione compounds showcases his expertise and commitment to advancing pharmaceutical science. His contributions continue to influence the development of new therapeutic agents.